A clinical pilot study of an oxides of nitrogen (NOx) - generating gel dressing system to stimulate healing in diabetic foot ulcers.

Trial Profile

A clinical pilot study of an oxides of nitrogen (NOx) - generating gel dressing system to stimulate healing in diabetic foot ulcers.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2015

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Acronyms ProNOx-1
  • Sponsors Edixomed
  • Most Recent Events

    • 25 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
    • 02 Jul 2015 Planned number of patients changed from 140 to 187 as reported by United Kingdom Clinical Research Network record.
    • 06 Nov 2013 Planned number of patients changed from 120 to 140 as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top